Showing results (41-50 of 203) with videos related to
Sort By:
Pageof 21
Expert Opinion on Pharmacotherapy|June 7, 2011
Expert opinion on current therapies for nonalcoholic fatty liver diseaseClaudia Della Corte, Anna Alisi, Raffaele Iorio, et al.Vaccine|May 21, 2011
Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girlClaudia Della Corte, Antonio Carlucci, Paola Francalanci, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 3, 2024
β-Klotho as novel therapeutic target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A narrative reviewMarica Meroni, Paola Dongiovanni, Francesca Tiano, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 25, 2005
Thyroid status affects rat liver regeneration after partial hepatectomy by regulating cell cycle and apoptosisAnna Alisi, Ilaria Demori, Silvana Spagnuolo, et al.International Journal of Molecular Sciences|November 22, 2013
ADAR enzyme and miRNA story: a nucleotide that can make the differenceSara Tomaselli, Barbara Bonamassa, Anna Alisi, et al.World Journal of Gastroenterology|November 12, 2014
MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseaseNadia Panera, Daniela Gnani, Annalisa Crudele, et al.The Journal of Pediatrics|March 11, 2014
Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese childrenStefano Cianfarani, Elena Inzaghi, Anna Alisi, et al.Plos One|September 1, 2012
Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cellsAnna Alisi, Mario Arciello, Stefania Petrini, et al.Cancers|July 12, 2020
Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal CancerManuela Porru, Pasquale Zizza, Nadia Panera, et al.BMC Medicine|May 5, 2009
The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver diseaseValerio Nobili, Anna Alisi, Andrea Vania, et al.Pageof 21